Incentives for Global Public Health: Patent Law and Access to Essential Medicines.

Thomas Pogge, Yale University
Matthew Rimmer, Australian National University College of Law
Kim Rubenstein, Australian National University College of Law

Abstract

Abstract: Introduction

Access to Essential Medicines: Public Health and International Law

Professor Thomas Pogge, Dr Matthew Rimmer, and Professor Kim Rubenstein

Part I International Trade

1. TRIPS and Essential Medicines: Must One Size Fit All? Making the WTO Responsive to the Global Health Crisis

Professor Rochelle Cooper Dreyfuss, New York University

2. The TRIPS Waiver as a Recognition of Public Health Concerns in the WTO

Associate Professor Andrew Mitchell and Associate Professor Tania Voon, University of Melbourne

3. Public Law Challenges to the Regulation of Pharmaceutical Patents in the US Bilateral Free Trade Agreements

Dr Hitoshi Nasu, The Australian National University

4. Global Health and Development: Patents and Public Interest

Associate Professor Elizabeth Siew Kuan Ng, National University of Singapore

Part II Innovation

5. The Health Impact Fund: Boosting Innovation without Obstructing Free Access

Professor Thomas Pogge, Yale University and The Australian National University

6. The Health Impact Fund: A Critique

Dr Kathleen Liddell, University of Cambridge

7. A Prize System as a Partial Solution to the Health Crisis in the Developing World

Professor William W. Fisher and Talha Syed, Harvard Law School

8. Innovation and Insufficient Evidence: The Case for a WTO-WHO Agreement on Health Technology Safety and Cost-Effectiveness Evaluation

Associate Professor Thomas Faunce, The Australian National University

Part III Intellectual Property

9. Opening the Dam: Patent Pools, Innovation, and Access to Essential Medicines

Professor Dianne Nicol and Dr Jane Nielsen, University of Tasmania

10. Open Source Drug Discovery: A Revolutionary Paradigm or a Utopian Model?

Dr Krishna Ravi Srinivas, Research Information System for Developing Countries (RIS), India

11. Accessing and Benefit Sharing Avian Influenza Viruses through the World Health Organisation: a CBD and TRIPS Compromise thanks to Indonesia’s Sovereignty Claim?

Dr Charles Lawson, Griffith University Faculty of Law and Associate Professor Barbara Hocking, Queensland University of Technology

12. The Lazarus Effect: The (RED) Campaign and Creative Capitalism

Dr Matthew Rimmer, The Australian National University

Part IV Health-Care

13. Beyond TRIPS: The Role of Non-state Actors and Access to Essential Medicines

Professor Noah Benjamin Novogrodsky, University of Toronto

14. Securing Health Through Rights

Katharine Young, Harvard University

15. The Role of National laws in Reconciling Constitutional Right to Health with TRIPS Obligations: An Examination of the Glivec Patent Case in India

Dr Rajshree Chandra, Delhi University

16. Tipping Point: Thai Compulsory Licenses Redefine Essential Medicines Debate

Jonathan Burton-MacLeod, The Australian National University

Bibliography